Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sonnet Biotherapeutics Holdings Inc
NASDAQ:SONN
|
US |
|
D
|
DGO Gold Ltd
F:48D
|
AU |
|
S
|
Sify Technologies Ltd
F:IWY1
|
IN |
|
S
|
Sidney Resources Corp
OTC:SDRC
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SONN's stock price target?
Not Available
SONN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Sonnet Biotherapeutics Holdings Inc?
Projected CAGR
5 384%
Over the last 3 years, the compound annual growth rate for Revenue has been -66%. The projected CAGR for the next 1 year is 5 384%.